跳至主要内容
临床试验/CTRI/2024/04/065382
CTRI/2024/04/065382尚未招募4 期

A comparative study to evaluate the efficacy and safety of oral tranexamic acid with triple combination cream versus triple combination cream monotherapy in the treatment of Melasma

MOHAN H N1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2024年4月18日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
52
试验地点
1
主要终点
Change in melasma area and severity index

研究概览

简要总结

Oral tranexamic acid is proved as a promising treatment option for melasma because of its demonstrated efficacy and limited side effect profile as a monotherapy and in combination with other modalities. Very few trials have been done regarding efficacy of oral tranexamic acid in Indian setting. so this study aims at comparing efficacy of combining oral tranexamic acid with triple combination cream versus triple combination cream alone in management of melasma.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Patients willing to give informed consent
  • Patients of either gender aged more than 18 years
  • Patients willing for follow up
  • Patients with clinically diagnosed melasma.

排除标准

  • Patient not willing to give informed consent
  • Patient already on melasma treatment with topical therapy within 2 weeks.
  • Pregnant and lactating females.
  • History of coexisting endocrinopathies.
  • History of thrombosis, thromboembolic episodes and altered blood coagulation profile.

结局指标

主要结局

Change in melasma area and severity index

时间窗: Change in melasma area and severity index at 4 weeks and 8 weeks

次要结局

  • Safety and tolerability parameters of study medications(At 4 weeks and 8 weeks)

研究者

发起方
MOHAN H N
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验